Sign up
Already have an account? Login
Saturday, June 6, 2026
21.2
C
Bengaluru
Hot topics
Does Public-Private Partnership Benefit The Public?
Does This Public-Private Partnership Benefit The Public?” (Tuesday, July...
Can Medicines Inject the Vitamins Amazon is Missing?
How Amazon’s Healthcare Bet May Change Indian Diagnostics and...
Violence Against Medics – Lessons to Draw from Private Hospitals
One interesting fact: most medical colleges and linked public hospitals in major cities were designed in the British era, with an open ward design. A medical administrator, tongue-in-cheek, put it succinctly: “When these hospitals were designed, nobody would have imagined that doctors will face violence”.
Time for design thinking in public healthcare delivery!
Has Indian Pharma Seen The Longevity Tsunami Coming?
Why India Must Urgently Reinvent Healthcare for a 100-Year...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Hot topics
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
In September 2011, MedicinMan published a UCPMP Special Issue...
Unmasking the Ethics of PCD Pharma Cos and the Incentives of Luxury Cars
🎁 The Diwali Dazzle: A Gilded Distraction?
In October 2025,...
Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?
Tata 1mg App Business Model: How does it work...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
Not Everything is a Problem to be Solved
As professionals, we are conditioned to be "fixers." We...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Newsletter
Get important news delivered directly to your inbox and stay connected!